Entero Therapeutics Inc. (ENTO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.56
-0.01 (-2.61%)
At close: Jan 15, 2025, 11:46 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
PE Ratio | -0.08 | -0.3 | -0.22 | -0.84 | -1.54 | -1.38 | -3.55 | -2.11 | -8.21 | -20.58 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.36 | 1.61 | -1.65 | -10.45 | 5.05K | 4.18 | 14.44 | 9.60 | -13.41K | 18.41K | n/a |
P/FCF Ratio | -0.1 | -0.2 | -0.3 | -2.46 | -611.64 | -1.67 | -5.46 | -6.78 | -11.61K | -40.45K | n/a |
P/OCF Ratio | -0.1 | -0.2 | -0.4 | -2.46 | -1.66K | -1.72 | -5.49 | -6.8 | -11.67K | -48.08K | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.23 | 0.32 | -0.13 | -0.24 | 0.33 | 0.06 | 0.15 | 0.05 | -1.81 | 0.40 | 3.72 |
Quick Ratio | 1.58 | 0.59 | 0.77 | 0.43 | 616.18 | 1.60 | 0.79 | 1.27 | 0.23 | 0.27 | 1.27 |
Current Ratio | 1.58 | 1.37 | 0.77 | 0.51 | 0.80 | 1.60 | 0.79 | 1.27 | 0.23 | 0.27 | 1.27 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -702.08 | -798.42 | -5.26K | -4.53 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -4.38 | -5.34 | 7.48 | 12.37 | -3.29K | -3.03 | -4.06 | -4.54 | 1.63K | -894.23 | -18.57 |
Return on Assets (ROA) | -2.29 | -2.69 | -4.97 | -2.53 | -1.70K | -1.81 | -1.69 | -2.16 | -887.01 | -359.68 | -1.02 |
Return on Capital (ROIC) | -4.21 | -4.29 | 115.70 | 10.08 | -3.19 | -0.00 | -0.00 | -0.00 | 2.22 | -0.7 | -3.77 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |